DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Consensus Recommendation of "Hold" from Brokerages

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) have been assigned an average recommendation of "Hold" from the thirteen research firms that are currently covering the stock, MarketBeat reports. Nine equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $26.33.

Several research firms have recently weighed in on XRAY. UBS Group lowered their price objective on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating for the company in a research note on Tuesday, December 3rd. Evercore ISI reiterated an "in-line" rating and set a $20.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Leerink Partnrs lowered shares of DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a research note on Thursday, November 7th. Barrington Research lowered their target price on DENTSPLY SIRONA from $36.00 to $24.00 and set an "outperform" rating on the stock in a research note on Friday, November 8th. Finally, Needham & Company LLC upped their price objective on DENTSPLY SIRONA from $23.00 to $25.00 and gave the company a "buy" rating in a research note on Thursday, January 30th.

DENTSPLY SIRONA Trading Down 2.3 %

NASDAQ:XRAY traded down $0.45 during trading hours on Tuesday, hitting $18.76. 1,454,966 shares of the company were exchanged, compared to its average volume of 2,340,175. The company has a fifty day simple moving average of $19.13 and a 200 day simple moving average of $22.29. DENTSPLY SIRONA has a one year low of $17.21 and a one year high of $34.91. The stock has a market capitalization of $3.73 billion, a price-to-earnings ratio of -9.06, a price-to-earnings-growth ratio of 1.88 and a beta of 0.96. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping analysts' consensus estimates of $0.48 by $0.02. The firm had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business's revenue was up .4% compared to the same quarter last year. During the same period last year, the business posted $0.49 EPS. Sell-side analysts expect that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were given a $0.16 dividend. The ex-dividend date of this dividend was Friday, December 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.41%. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -30.92%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in XRAY. Sequoia Financial Advisors LLC grew its stake in shares of DENTSPLY SIRONA by 35.8% during the fourth quarter. Sequoia Financial Advisors LLC now owns 11,556 shares of the medical instruments supplier's stock valued at $219,000 after buying an additional 3,048 shares during the last quarter. HighTower Advisors LLC lifted its holdings in DENTSPLY SIRONA by 41.3% in the 4th quarter. HighTower Advisors LLC now owns 24,480 shares of the medical instruments supplier's stock worth $465,000 after buying an additional 7,152 shares during the period. AGF Management Ltd. bought a new stake in DENTSPLY SIRONA in the fourth quarter valued at $2,535,000. Cooke & Bieler LP increased its position in shares of DENTSPLY SIRONA by 24.3% during the fourth quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier's stock valued at $174,101,000 after buying an additional 1,794,391 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of DENTSPLY SIRONA by 35.2% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 58,213 shares of the medical instruments supplier's stock worth $1,105,000 after acquiring an additional 15,162 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.